Industry-University Cooperation Foundation Hanyang University

Irfan Ullah

Priti Kumar

Sang-Kyung Lee

Sangah Lee

Kun Ho Chung

Min Hyung Lee

Jung Ju Oh

Kunho Chung

A nose-to-brain drug delivery device is provided. The nose-to-brain drug delivery device includes a freeze-dried drug container for storing a freeze-dried drug, a restoring solvent container for storing a solvent for thawing the freeze-dried drug, a membrane for preventing the freeze-dried drug from being mixed with the solvent, and a compressor for providing a driving force. The membrane is opened by the driving force of the compressor to mix the freeze-dried drug with the solvent, thereby thawing the freeze-dried drug, and the thawed drug is sprayed by the driving force of the compressor.

Nose-to-brain drug delivery device

A test device is disclosed. The test device includes a supporter providing a seating surface for an experimental animal, and a chair formed on the supporter and configured to induce a drug inhalation posture in which a head of the experimental animal is directed downward. Thus, a mecca position may be induced by a simple operation of seating an unconscious experimental animal on the chair. As a result, nose-to-brain drug delivery may be performed.

Test device and test method using the same

The present invention relates to a nasal administration composition for preventing or treating ischemic cerebrovascular disease, containing a Fas targeting peptide (FTP). When using the pharmaceutical composition or kit of the present invention, a drug can be effectively delivered to brain tissue and the ischemic cerebrovascular disease of a subject can be effectively prevented or treated.

Composition for treating apoplexy through nasal administration

Growing community of inventors

Seoul, South Korea

Irfan Ullah